Safe Orthopaedics SA represents a strong commitment to patient safety, innovation, and excellence in orthopaedic care. The company focuses on developing and commercializing sterile single-use implants and instruments for minimally invasive surgery. Safe Orthopaedics SA values patient well-being above all and strives to provide healthcare professionals with cutting-edge solutions to improve surgical outcomes. The company's corporate philosophy revolves around creativity, collaboration, and a patient-centric approach. By continuously investing in research and development, Safe Orthopaedics SA aims to revolutionize the orthopaedic field and contribute to the advancement of patient care worldwide.

Safe Orthopaedics SA is primarily present in various countries and regions worldwide. Some of the key locations where the company operates include France, Germany, the United Kingdom, Italy, Spain, Switzerland, the United States, and several other European and international markets. With its global presence, Safe Orthopaedics SA aims to provide innovative orthopedic solutions and cater to the needs of patients and healthcare professionals across multiple geographical areas.

Safe Orthopaedics SA has achieved several significant milestones. The company successfully launched and commercialized its flagship spinal implant products, such as SteriSpine™ PS and SteriSpine™ CC. These innovative solutions have been embraced by healthcare professionals worldwide, leading to increased market share and revenue growth for Safe Orthopaedics SA. Additionally, the company has established strategic partnerships and distribution agreements with key players in the orthopedic industry, expanding its global reach and enhancing its brand visibility. Safe Orthopaedics SA continues to develop and introduce advanced technologies, positioning itself as a leading player in the orthopedic implant sector.

Safe Orthopaedics SA is a renowned medical technology company specializing in innovative solutions for spinal surgeries. Founded in 2010, Safe Orthopaedics has established a strong presence in the orthopedic industry with its cutting-edge implant technologies and comprehensive surgical kits. The company's mission is to simplify and improve spinal surgeries by providing surgeons with reliable and efficient tools. Safe Orthopaedics SA has a track record of advancing patient care through its expertise in designing and manufacturing high-quality implants. With a commitment to continuous innovation and patient-centric solutions, Safe Orthopaedics has cemented its position as a leader in the orthopedic market.

Some of the main competitors of Safe Orthopaedics SA in the market include major players in the orthopedic industry such as Medtronic, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., and NuVasive Inc. These companies have a strong presence and offer a wide range of orthopedic products and solutions similar to Safe Orthopaedics SA. With their established market positions and extensive product portfolios, these competitors pose a challenge to Safe Orthopaedics SA's market share and growth opportunities.

Safe Orthopaedics SA is primarily active in the medical devices industry, specifically focusing on spinal surgery solutions.

The business model of Safe Orthopaedics SA revolves around providing innovative and safe orthopedic solutions. Safe Orthopaedics specializes in developing and commercializing a range of sterile single-use instruments and implants for spine surgeries. The company aims to improve patient outcomes by offering efficient and cost-effective solutions to surgeons. Safe Orthopaedics supplies its products to hospitals and healthcare facilities, addressing the need for reliable and safe orthopedic interventions. With a focus on quality, safety, and innovation, Safe Orthopaedics SA strives to enhance the orthopedic care landscape and contribute to the advancement of spinal surgery practices.

Det Safe Orthopaedics P/E-forhold er -0,00.

Safe Orthopaedics KUV er 0,00.

AlleAktien Kvalitetsscore for Safe Orthopaedics er 7/10.

Den forventede Safe Orthopaedics omsætning er 7,93 mio. EUR.

Den forventede Safe Orthopaedics indtjening er -250,21 mio. EUR.

Safe Orthopaedics SA is a company that operates in the field of medical technology and specializes in the development of innovative products for spinal surgery. The company's business model consists of various divisions that are all focused on the development and marketing of products for orthopedics. One of the company's most important divisions is research and development. Safe Orthopaedics SA works closely with surgeons, scientists, and engineers to develop new products and technologies that meet the needs of patients and surgeons. Modern materials and manufacturing methods are used to achieve the highest precision and quality in implant production. Another important part of Safe Orthopaedics SA's business model is the marketing of the developed products. The company has a distribution network consisting of various partners and dealers who distribute Safe Orthopaedics SA products worldwide. In addition, the company strives to build strong customer relationships by offering training and continuing education for surgeons and medical personnel. The product range of Safe Orthopaedics SA includes various implants and instruments for spinal surgery. A key product of the company is the SteriSpine® PS System, a platform designed to improve precision, efficiency, and safety in spinal surgery. The system consists of sterilization bags and single-use instruments that avoid repeated autoclaving and reduce the risk of infection. Another important product of Safe Orthopaedics SA is the Sepalif® System, specifically designed for minimally invasive procedures in the lumbar spine. It allows the surgeon to maneuver the anatomy of the spine precisely and provides a higher level of safety and efficiency in minimally invasive procedures. In summary, the business model of Safe Orthopaedics SA is based on close collaboration with experts and the use of state-of-the-art technologies and materials. The company aims to develop innovative products that contribute to making spinal surgery safer, more effective, and more precise. Through strong customer relationships and a global distribution network, Safe Orthopaedics SA strives to exceed the expectations of surgeons and patients and play a leading role in medical technology.

Safe Orthopaedics udbetaler et udbytte på 0 EUR fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Safe Orthopaedics, eller selskabet udbetaler ikke udbytte.

ISIN'en for Safe Orthopaedics er FR0013467123.

WKN for Safe Orthopaedics er A2PW9B.

Tickeren for Safe Orthopaedics er ALSAF.PA.

I løbet af de sidste 12 måneder betalte Safe Orthopaedics en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Safe Orthopaedics sandsynligvis betale en dividende på 0 EUR.

Udbytteafkastet for Safe Orthopaedics er i øjeblikket .

Safe Orthopaedics betaler kvartalsvis udbytte. Dette uddeles i månederne .

Safe Orthopaedics betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 EUR. Dette svarer til et dividendeafkast på 0 %.

Safe Orthopaedics bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Safe Orthopaedics fra den 8.9.2024 på 0 EUR, skulle du have haft aktien i din portefølje før ex-datoen den 8.9.2024.

Udbetalingen af det sidste udbytte blev foretaget den 8.9.2024.

I løbet af 2023 udbetalte Safe Orthopaedics 0 EUR i form af dividender.

Udbytterne fra Safe Orthopaedics udbetales i EUR.